HiberCell
Kyle Michel has 8 years of experience in the biotechnology industry. Kyle began their career in 2011 as a Research Associate at Biothera Pharmaceuticals, Inc. where they became proficient with analytical instrumentation and supported the biology team by producing fluorescently tagged test molecules for ex vivo and in vivo animal studies. Kyle then took on the role of Research Scientist where they developed a process to purify mannan oligosaccharides from yeast and successfully scaled the process from benchtop to pilot plant. In 2020, they joined HiberCell as Manager of Quality.
Kyle Michel attended the University of Minnesota-Morris from 2007 to 2011, where they graduated with a Bachelor of Arts (B.A.) in Chemistry.
This person is not in any teams
This person is not in any offices
HiberCell
2 followers
Despite significant advances in treatment of primary tumors, metastatic cancer remains a leading cause of solid cancer mortality. HiberCell seeks to change that. As “the dormancy company,” they are the first company exclusively focused on therapeutically modulating the biology and mechanisms of tumor dormancy.